(Q37330158)

19 August 2017

1 reference

title

Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies (English)

1 reference

19 August 2017

main subject

cerebrovascular disease

1 reference

Daniele Tomassoni

1

1 reference

19 August 2017

Alessia Lanari

2

1 reference

19 August 2017

Giorgio Silvestrelli

3

1 reference

19 August 2017

Enea Traini

4

1 reference

19 August 2017

Francesco Amenta

5

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Clinical and Experimental Hypertension

19 August 2017

published in

1 reference

19 August 2017

volume

30

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

744-766

1 reference

Three types of neuronal calcium channel with different calcium agonist sensitivity.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Calcium channels in cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Pharmacology of nimodipine. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Human pial vascular reactions to intravenous Nimodipine-infusion during EC-IC bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Receptor sites for Ca2+ channel antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Subarachnoid haemorrhage: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Effect of nimodipine on cerebral blood flow and cerebrovascular reactivity after subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Smaller local brain volumes and cerebral atrophy in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Microanatomical changes of intracerebral arteries in spontaneously hypertensive rats: a model of cerebrovascular disease of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Hypertensive brain damage: comparative evaluation of protective effect of treatment with dihydropyridine derivatives in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine facilitates associative learning in aging rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Effects of nimodipine on learning in normotensive and spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Role of calcium antagonists in cerebral arterial spasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine disposition and haemodynamic effects in patients with cirrhosis and age-matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine. Potential for drug-drug interactions in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine improves the disruption of spatial cognition induced by cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

The effects of the pre-treatment of intravenous nimodipine on Na(+)-K+/Mg+2 ATPase, Ca+2/Mg+2 ATPase, lipid peroxidation and early ultrastructural findings following middle cerebral artery occlusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Combined nimodipine and citicoline reduce infarct size, attenuate apoptosis and increase bcl-2 expression after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

The effects of LY393613, nimodipine and verapamil, in focal cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Cardiovascular responses and nitric oxide production in cerebral ischemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Increase in receptor binding affinity for nimodipine in the rat brain with permanent occlusion of bilateral carotid arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine modulates Bcl-2 and Bax mRNA expression after cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Historical overview. Calcium, ischemia, and death of brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Differential effects of dihydropyridine calcium channel blockers in kainic acid-induced experimental seizures in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

The influence of nimodipine, nicardipine and amlodipine on the brain free fatty acid level in rats with penicillin-induced seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Augmentation by calcium channel antagonists of general anaesthetic potency in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Calcium channel antagonists decrease the ethanol withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Dose-finding study with nimodipine: a selective central nervous system calcium channel blocker on aminophylline induced seizure models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Effects of the dihydropyridine Ca2+ channel antagonist nimodipine on kainic acid-induced limbic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine treatment to assess a modified mouse model of intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Aneurysmal subarachnoid hemorrhage: prevention of delayed ischemic dysfunction with intravenous nimodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Survey of clinical experience with nimodipine in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Subarachnoid haemorrhage: difficulties in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

21 January 2018

Subarachnoid haemorrhage

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Cerebral Arterial Spasm – A Controlled Trial of Nimodipine in Patients with Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

The International Cooperative Study on Timing of Aneurysm Surgery--an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

A controlled trial of nimodipine in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Double-blind evaluation of glycerol therapy in acute cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Blood pressure, nimodipine, and outcome of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Widespread cerebral ischaemia treated with nimodipine in a patient with eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Effect of prophylactic administration of nimodipine in patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Nimodipine for treatment of primary thunderclap headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

Calcium antagonists in cerebral/peripheral vascular disorders. Current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10641960802580232

10.1080/10641960802580232

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference